|
Market Closed -
Nasdaq
21:00:00 23/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 250.69 USD | -1.24% |
|
+7.75% | +42.45% |
| 10-22 | BofA Securities Adjusts Biogen Price Target to $244 From $219 | MT |
| 10-21 | TD Cowen Adjusts Price Target on Biogen to $250 From $225 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 37.04B | |||||
| 1,135B | |||||
| 636B | |||||
| 505B | |||||
| 378B | |||||
| 358B |
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
